Morton's Neuroma
7
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
10 treatments under study, led by Xylocaine
Research Leaders
8 sponsors active, led by Centrexion Therapeutics
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (7)
Resiniferatoxin for the Management of Refractory Morton s Neuroma Pain
Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain
Cryoanalgesia for the Treatment of Pain in Subjects With Morton's Neuroma
A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
Study to Evaluate the Safety and Tolerability of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
A Study to Characterize the Phenotype in Patients With Morton's Neuroma and to Explore the Effect of Local Administration of Xylocaine (Lidocaine)
Comparison of Alcohol and Steroid Injection for Treating Morton's Neuroma
Research Network
Common Treatments
- Xylocaine1
- Standard Neurectomy1
- Injection Of Lidocaine Into Foot1
- Injection Of Steroid Into Foot1
- Injection Of Alcohol Into Foot1
Active Sponsors
- Centrexion Therapeutics2
- Pacira Pharmaceuticals, Inc1
- National Institutes of Health Clinical Center (CC)1
- Axogen Corporation1
- NorthBay Healthcare1
Top Investigators
NorthBay Healthcare
Rhode Island Hospital, Brown Medical School
AstraZeneca R&D Södertälje, Sweden
National Institutes of Health Clinical Center (CC)
Related Conditions
- Pain Management1
- Symptomatic Neuroma1
- Chronic Nerve Pain1